COMPOSITIONS AND USES OF ET743 FOR TREATING CANCER
ЕТ743 намира приложение в хуманната медицина за лечение на рак. ЕТ743 се прилага в доза от 1000-1650 g/m2 телесна повърхност чрез интравенозна инфузия в продължение на 3 до 24 h, провеждана на многократни цикли всеки с времетраене от 3-4 седмици, сединично прилагане на лекарството в първия от всеки...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | bul ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MISSET, JEAN L TWELVES, CHRIS VON HOFF, DANIEL D DEMETRI, GEORGE D LAZARO, LUIS L CVITKOVIC, ESTEBAN JIMENO, JOSE GUZMAN, CECILIA |
| description | ЕТ743 намира приложение в хуманната медицина за лечение на рак. ЕТ743 се прилага в доза от 1000-1650 g/m2 телесна повърхност чрез интравенозна инфузия в продължение на 3 до 24 h, провеждана на многократни цикли всеки с времетраене от 3-4 седмици, сединично прилагане на лекарството в първия от всеки цикъл.
ET743 is used in human medicine for the treatment of cancer. ET743 is applied in a dose of 1000-1650 g/m2 body surface by intravenous infusion for 3 to 24 h, carried out in multiple cycles, with single administration of the medicine in the first of each cycles. 11 claims. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BG106171A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BG106171A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BG106171A3</originalsourceid><addsrcrecordid>eNrjZDBy9vcN8A_2DPH09wtWcPRzUQgNdg1W8HdTcA0xNzFWcPMPUggJcnUM8fRzV3B29HN2DeJhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfFO7oYGZobmho7GBBUAAHZVJRo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND USES OF ET743 FOR TREATING CANCER</title><source>esp@cenet</source><creator>MISSET, JEAN L ; TWELVES, CHRIS ; VON HOFF, DANIEL D ; DEMETRI, GEORGE D ; LAZARO, LUIS L ; CVITKOVIC, ESTEBAN ; JIMENO, JOSE ; GUZMAN, CECILIA</creator><creatorcontrib>MISSET, JEAN L ; TWELVES, CHRIS ; VON HOFF, DANIEL D ; DEMETRI, GEORGE D ; LAZARO, LUIS L ; CVITKOVIC, ESTEBAN ; JIMENO, JOSE ; GUZMAN, CECILIA</creatorcontrib><description>ЕТ743 намира приложение в хуманната медицина за лечение на рак. ЕТ743 се прилага в доза от 1000-1650 g/m2 телесна повърхност чрез интравенозна инфузия в продължение на 3 до 24 h, провеждана на многократни цикли всеки с времетраене от 3-4 седмици, сединично прилагане на лекарството в първия от всеки цикъл.
ET743 is used in human medicine for the treatment of cancer. ET743 is applied in a dose of 1000-1650 g/m2 body surface by intravenous infusion for 3 to 24 h, carried out in multiple cycles, with single administration of the medicine in the first of each cycles. 11 claims.</description><edition>7</edition><language>bul ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020628&DB=EPODOC&CC=BG&NR=106171A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020628&DB=EPODOC&CC=BG&NR=106171A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MISSET, JEAN L</creatorcontrib><creatorcontrib>TWELVES, CHRIS</creatorcontrib><creatorcontrib>VON HOFF, DANIEL D</creatorcontrib><creatorcontrib>DEMETRI, GEORGE D</creatorcontrib><creatorcontrib>LAZARO, LUIS L</creatorcontrib><creatorcontrib>CVITKOVIC, ESTEBAN</creatorcontrib><creatorcontrib>JIMENO, JOSE</creatorcontrib><creatorcontrib>GUZMAN, CECILIA</creatorcontrib><title>COMPOSITIONS AND USES OF ET743 FOR TREATING CANCER</title><description>ЕТ743 намира приложение в хуманната медицина за лечение на рак. ЕТ743 се прилага в доза от 1000-1650 g/m2 телесна повърхност чрез интравенозна инфузия в продължение на 3 до 24 h, провеждана на многократни цикли всеки с времетраене от 3-4 седмици, сединично прилагане на лекарството в първия от всеки цикъл.
ET743 is used in human medicine for the treatment of cancer. ET743 is applied in a dose of 1000-1650 g/m2 body surface by intravenous infusion for 3 to 24 h, carried out in multiple cycles, with single administration of the medicine in the first of each cycles. 11 claims.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBy9vcN8A_2DPH09wtWcPRzUQgNdg1W8HdTcA0xNzFWcPMPUggJcnUM8fRzV3B29HN2DeJhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfFO7oYGZobmho7GBBUAAHZVJRo</recordid><startdate>20020628</startdate><enddate>20020628</enddate><creator>MISSET, JEAN L</creator><creator>TWELVES, CHRIS</creator><creator>VON HOFF, DANIEL D</creator><creator>DEMETRI, GEORGE D</creator><creator>LAZARO, LUIS L</creator><creator>CVITKOVIC, ESTEBAN</creator><creator>JIMENO, JOSE</creator><creator>GUZMAN, CECILIA</creator><scope>EVB</scope></search><sort><creationdate>20020628</creationdate><title>COMPOSITIONS AND USES OF ET743 FOR TREATING CANCER</title><author>MISSET, JEAN L ; TWELVES, CHRIS ; VON HOFF, DANIEL D ; DEMETRI, GEORGE D ; LAZARO, LUIS L ; CVITKOVIC, ESTEBAN ; JIMENO, JOSE ; GUZMAN, CECILIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BG106171A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>bul ; eng</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MISSET, JEAN L</creatorcontrib><creatorcontrib>TWELVES, CHRIS</creatorcontrib><creatorcontrib>VON HOFF, DANIEL D</creatorcontrib><creatorcontrib>DEMETRI, GEORGE D</creatorcontrib><creatorcontrib>LAZARO, LUIS L</creatorcontrib><creatorcontrib>CVITKOVIC, ESTEBAN</creatorcontrib><creatorcontrib>JIMENO, JOSE</creatorcontrib><creatorcontrib>GUZMAN, CECILIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MISSET, JEAN L</au><au>TWELVES, CHRIS</au><au>VON HOFF, DANIEL D</au><au>DEMETRI, GEORGE D</au><au>LAZARO, LUIS L</au><au>CVITKOVIC, ESTEBAN</au><au>JIMENO, JOSE</au><au>GUZMAN, CECILIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND USES OF ET743 FOR TREATING CANCER</title><date>2002-06-28</date><risdate>2002</risdate><abstract>ЕТ743 намира приложение в хуманната медицина за лечение на рак. ЕТ743 се прилага в доза от 1000-1650 g/m2 телесна повърхност чрез интравенозна инфузия в продължение на 3 до 24 h, провеждана на многократни цикли всеки с времетраене от 3-4 седмици, сединично прилагане на лекарството в първия от всеки цикъл.
ET743 is used in human medicine for the treatment of cancer. ET743 is applied in a dose of 1000-1650 g/m2 body surface by intravenous infusion for 3 to 24 h, carried out in multiple cycles, with single administration of the medicine in the first of each cycles. 11 claims.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | bul ; eng |
| recordid | cdi_epo_espacenet_BG106171A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPOSITIONS AND USES OF ET743 FOR TREATING CANCER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T15%3A55%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MISSET,%20JEAN%20L&rft.date=2002-06-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBG106171A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |